Hartford Great Health Corp.
HFUS · OTC
10/31/2025 | 7/31/2025 | 4/30/2025 | 1/31/2025 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.68 | 0.01 | -10.94 | 24.85 |
| FCF Yield | -0.39% | -0.03% | -0.11% | -0.15% |
| EV / EBITDA | 473.17 | 184.90 | 790.76 | 518.85 |
| Quality | ||||
| ROIC | 3.10% | 240.75% | 7.54% | 12.31% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | -3.86 | -0.05 | -1.75 | -1.14 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,238,027.93% | 1,267,168.71% | 118.01% | 77.33% |
| Free Cash Flow Growth | -413.68% | 76.06% | 3.00% | -147.16% |
| Safety | ||||
| Net Debt / EBITDA | 12.08 | -0.08 | 21.96 | 17.98 |
| Interest Coverage | 47.49 | 443.14 | 0.00 | 803.86 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 34.57 | -1,415.94 | 264.27 | 191.38 |